Vol. 5 No. 2 (1999)
Case Report

Progressive Limb Weakness and Sensory Loss in a Young Woman

Published 2020-12-01

Keywords

  • hereditary neuropathy with liability to pressure palsies,
  • HNPP,
  • tomaculous neuropathy,
  • neurology

How to Cite

1.
Glass H, Srour M, Pari G, Karpati G, Snipes GJ. Progressive Limb Weakness and Sensory Loss in a Young Woman. McGill J Med [Internet]. 2020 Dec. 1 [cited 2025 Oct. 8];5(2). Available from: https://mjm.mcgill.ca/article/view/748

Abstract

Patients with neuromuscular disease often present with a combination of symptoms that suggest a wide differential diagnosis. Traditionally, electrophysiologic studies and microscopy have aided the clinician in making a diagnosis. More recently, genetic testing for specific diseases has helped to ensure correct diagnosis. The following is a case that emphasizes the importance of combining clinical, electrophysiologic, microscopic and finally, genetic findings.

Downloads

Download data is not yet available.

References

  1. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103: 259- 280; 1980.
  2. Davies DM. Recurrent peripheral-nerve palsies in a family. Lancet 2: 266-268; 1954.
  3. Dyck PJ, Thomas PK, Lambert R, et al. (eds). Peripheral Neuropathy, 3rd edition. Toronto: W.B. Saunders Company; 1993.
  4. Behse F, Buchthal F, Carlsen F. Hereditary neuropathy with liability to pressure palsies: electrophysiological and histopathological aspects. Brain 95: 777-794; 1972.
  5. Nelson JS, Parisi JE, Schichet SS (eds.). Principles and Practice of Neuropathology, 3rd Edition. St. Louis: Mosby; 1993.
  6. Madrid R, Bradley WG, Davis CJF. The peroneal muscular atrophy syndrome. Journal of Neurological Sciences 32: 91-122; 1977.
  7. Malandrini A, Guazzi GC, Federico A. Sensori-motor polyneuropathy in two siblings: atypical presentation of tomaculous neuropathy. Clinical Neuropathology 11: 318-322; 1992.
  8. Nardelli E, Pizziguella S, Tridente G, Rizzuro N. Peripheral neuropathy associated with immunological disorders. An immunological and ultrastuctural study. Acta Neuropathologica suppl VII 258-261; 1981.
  9. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP- 22/SR13). Journal of Cell Biology 117: 225-38; 1982.
  10. Fabretti E, Edomi P, Brancolini C, Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes and Development 9: 1846-1856; 1995.
  11. Zoidl G, Blass-Kampmann S, D’Urso D, et al. Retroviral- mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. The EMBO Journal 14: 1122-1128; 1995.
  12. Suter U, Moskow JJ, Welcher AA, et al. A leucine-to-proline mutation in the putative first transmembrane domain of the 22- kDa peripheral myelin protein in the trembler-J mouse. Proceedings of the National Academy of Sciences USA 89: 4382-4386; 1992.
  13. Adlkofer K, Martini R, Agussi A, et al. Hypermyelination and demyelinating peripheral neuropathy in pmp22-deficient mice. Nature Genetics 11: 274-280; 1995.
  14. Magyar JP, Martini R, Ruelicke T, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP-22 gene dosage. Journal of Neuroscience 16: 5351-5360; 1996.
  15. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clinical Genetics 6: 98-118; 1974.